Advancing Gene Therapy Potency Testing with iPSC-Based Systems
Revolutionizing Cardiac Safety Assessment with NHP Cardiomyocytes
A Reduction in Animal Testing Stems From Ncardia

See How Ncardia Is Supporting the Shift From Animal Models With iPSC Technology
Advancing High-Throughput Cardiac Screening With Physiologically Relevant 3D iPSC-Based Models
.png)
Breaking New Ground in ALS Research
